ATHA (Athira Pharma Corp) Bozor qiymatining balans qiymatiga nisbati
Athira Pharma, Inc. (ATHA) ommaviy ishlab chiqarish davomida minimal xarajatlarni ta'minlaydigan patentlardan foydalangan holda, Altsgeymer kasalligiga qarshi kurashish usullarini ishlab chiqmoqda. Test robotizatsiyasi va molekulalarni avtomatlashtirilgan holda aniqlash ilmiy progressni tezlashtirmoqda. Ushbu narxlar grafigi aktivning dinamikasini aks ettiradi, bunda ko'rsatkich 0.99 darajasida turibdi. Biroq, moliyalashtirish yetishmovchiligi va tadqiqotlarning erta bosqichlaridagi muvaffaqiyatsizlik xavfi aksiyalar narxiga sezilarli bosim o'tkazmoqda.
%20Kapitallashuvning%20balans%20qiymatiga%20nisbati&width=1200&height=400&colorIndex=0&v=mvrk6wqv.ssk-7as46ww&start=20220704&end=20261028&filename=GURU_Markets_-_ATHA_-_Athira-Pharma-Inc._-_Capitalization-to-Book-Value-Ratio "ATHA Athira Pharma Bozor kapitallashuvining balans qiymatiga nisbati (04.07.2022 - 12.01.2026) | 👁️GURU.Markets👁️")
Athira Pharma Inc (ATHA) moliyaviy va bozor koʻrsatkichlari kesimi
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi bo'yicha ma'lumotlar:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz va likvidlik bo'yicha ma'lumotlar:
Qarzning xususiy kapitalga nisbati Athira Pharma, Inc.|ATHA - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Athira|ATHA - Kompaniyaning umumiy yig'indi qarzi|Balans kapitallashuviga qarzlar Athira|ATHA - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Athira Pharma
Kompaniyaning dastlabki tahlili:Athira Pharma, Inc. - ATHA
Ushbu ko'rsatkich joriy bozor kapitalizatsiyasining kapital miqdoriga nisbati sifatida hisoblanadi. Mazkur metrika aktivlarning haddan tashqari qimmat baholanganlik darajasini yoki ularning balans qiymatiga nisbatan chegirma darajasini belgilaydi. Athira Pharma, Inc. (ATHA) uchun bu juda muhimdir, chunki Altsgeymer terapiyasi borasidagi muvaffaqiyatsizliklardan so'ng tadqiqot va ishlanmalar (R&D) strategiyasining qayta ko'rib chiqilishi kapital qiymatiga bo'lgan ishonchni zaiflashtiradi. Narxning balans qiymatiga nisbatini tahlil qilish orqali investor aktivlarning qadrsizlanishi bilan bog'liq real xavfni aniqlashi mumkin.
Asosiy raqobatchilar
BIIB: Bozor kapitallashuvining balans qiymatiga nisbati|NBIX (neurocrine.com) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Regencell Bioscience Holdings Limited (RGC)|Kapitallashuvning balans qiymatiga nisbati Axsome|ACADIA Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenon Corp XENE|Kapitallashuvning sof aktivlarga nisbati VKTX (Viking Therapeutics)|supernus.com - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Catalyst Pharmaceuticals, Inc. (CPRX)|DNLI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HRMY|Biohaven Corp (BHVN) - Bozor qiymatining balans qiymatiga koeffitsiyenti|AMLX (Amylyx Pharmaceuticals) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati trevitherapeutics.com (TRVI)|Kapitallashuvning sof aktivlarga nisbati Praxis Precision Medicines, Inc.|Bozor kapitallashuvining balans qiymatiga multiplikatori Anavex (AVXL)|Bozor kapitallashuvining balans qiymatiga nisbati CeriBell Corp|Balans qiymatiga nisbatan bozor qiymati Prothena PRTA|Bozor kapitallashuvining balans qiymatiga nisbati ALEC (Alector Therapeutics)|ANNX: Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati omeros.com OMER|Neurogene Inc (NGNE) - Balans qiymatiga nisbatan bozor qiymati|ACIU (AC Immune Corp) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Voyager Corp (VYGR)|Neumora Therapeutics (NMRA) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati SCLX (scilexholding.com)|Tevogen Bio (TVGN) - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi Alpha Cognition Inc ACOG|Bozor kapitallashuvining balans qiymatiga nisbati Cognition Therapeutics, Inc. (CGTX)|IKT - Balans qiymatiga nisbatan bozor qiymati|SAVA: Bozor kapitallashuvining balans qiymatiga nisbati|ASRT (Assertio) - Bozor kapitallashuvining balans qiymatiga nisbati|COYA - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati VTGN|Bozor qiymatining balans qiymatiga nisbati OVID (Ovid Therapeutics Inc.)|Kapitallashuvning sof aktivlarga nisbati Acumen Pharmaceuticals, Inc (ABOS)|Bozor kapitallashuvining balans qiymatiga nisbati CRVO (CervoMed Inc.)|ATHE - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Clene Nanomedicine (CLNN)|PEPG - Balans qiymatiga nisbatan bozor qiymati|Jupiter Neurosciences - Bozor kapitallashuvining balans qiymatiga nisbati|RLMD (Relmada Corp) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Annovis Bio, Inc. (ANVS)|Kapitallashuvning balans qiymatiga nisbati Grace Tx|Bozor kapitallashuvining balans qiymatiga nisbati AIFF (Firefly Neuroscience)|Kapitallashuvning sof aktivlarga nisbati anewmeds.com KLTO|Kapitallashuvning sof aktivlarga nisbati NRSN|Balans qiymatiga nisbatan bozor kapitallashuvi Reviva Pharmaceuticals, Inc. RVPH|MetaVia, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|neuraxis.com (NRXS) - Bozor kapitallashuvining balans qiymatiga nisbati|HSDT - Kapitallashuvning sof aktivlarga nisbati|Passage Bio (PASG) - Bozor kapitallashuvining balans qiymatiga multiplikatori|NEUP - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Minerva|Bozor kapitallashuvining balans qiymatiga nisbati ADXN|Bozor kapitallashuvining balans qiymatiga nisbati ALZN (alzamend.com)|CYCN - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati Protagenic Therapeutics Inc. PTIX|KTTA (Pasithea) - Bozor kapitallashuvining balans qiymatiga nisbati|Cortigent, Inc. (CRGT) - Bozor qiymatining balans qiymatiga koeffitsiyenti|ATXI: Kapitallashuvning sof aktivlarga nisbati|BCLI (brainstorm-cell.com) - Bozor kapitallashuvining balans qiymatiga nisbati|CARA - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CHRO|Eliem Therapeutics - Bozor qiymatining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti intracellulartherapies.com (ITCI)|Bozor kapitallashuvining balans qiymatiga nisbati LBPH (Longboard Pharmaceuticals)|MRNS - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati NKGen Biotech NKGN|NRBO - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati Sage Therapeutics, Inc SAGE|Synaptogenix, Inc (SNPX) - Balans qiymatiga nisbatan bozor qiymati|TRVN: Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi VIGL|Anew Medical, Inc. (WENA) - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati Cerevel Therapeutics Inc (CERE)